These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2114021)
1. Evaluation of free tissue concentrations of fleroxacin after oral administration. Limberg J; LeBel M; Derendorf H Pharm Res; 1990 Apr; 7(4):422-4. PubMed ID: 2114021 [No Abstract] [Full Text] [Related]
2. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens. Panneton AC; Bergeron MG; LeBel M Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338 [TBL] [Abstract][Full Text] [Related]
3. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue. Kees F; Naber KG; Schumacher H; Grobecker H Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456 [TBL] [Abstract][Full Text] [Related]
4. Comparative oral pharmacokinetics of fleroxacin and pefloxacin. De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343 [TBL] [Abstract][Full Text] [Related]
5. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Jynge P; Skjetne T; Gribbestad I; Kleinbloesem CH; Hoogkamer HF; Antonsen O; Krane J; Bakøy OE; Furuheim KM; Nilsen OG Clin Pharmacol Ther; 1990 Nov; 48(5):481-9. PubMed ID: 2121409 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone. Wise R; Kirkpatrick B; Ashby J; Griggs DJ Antimicrob Agents Chemother; 1987 Feb; 31(2):161-3. PubMed ID: 3105446 [TBL] [Abstract][Full Text] [Related]
7. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study. Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the penetration of two quinolones into intra-abdominal abscess. Tudor RG; Youngs DJ; Yoshioka K; Burdon DW; Keighley MR Arch Surg; 1988 Dec; 123(12):1487-90. PubMed ID: 3142444 [TBL] [Abstract][Full Text] [Related]
9. The metabolism and pharmacokinetics of fleroxacin in healthy subjects. Griggs DJ; Wise R; Kirkpatrick B; Ashby JP J Antimicrob Chemother; 1988 Oct; 22 Suppl D():191-4. PubMed ID: 3144537 [TBL] [Abstract][Full Text] [Related]
10. Altered disposition of fleroxacin in patients with cystic fibrosis. Mimeault J; Vallée F; Seelmann R; Sörgel F; Ruel M; LeBel M Clin Pharmacol Ther; 1990 May; 47(5):618-28. PubMed ID: 2111750 [TBL] [Abstract][Full Text] [Related]
11. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans. Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone. Weidekamm E; Stöckel K; Dell D Chemioterapia; 1987 Jun; 6(2 Suppl):307-8. PubMed ID: 3151346 [No Abstract] [Full Text] [Related]